Villamor, Orle A.

HRN: 17-92-62  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/21/2025
CEFAZOLIN 1GM (VIAL)
01/23/2025
01/23/2025
IV
1g
Single Dose
Removal Of Implant
Waiting Final Action 

Indication:  Prophylaxis    Type of Infection:  Bone & JointSkin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: